Insider Buying: Mobia Medical (NASDAQ:MOBI) Director Acquires $184,472.86 in Stock

Key Points

• Director Casey Tansey bought 15,821 Mobia Medical shares at an average price of $11.66, investing $184,472.86 and increasing their ownership by 5.88% to 284,725 shares.
• MOBI shares traded at $11.74, near the lower end of their 52-week range of $10.19 to $15.29. The company reported quarterly revenue growth of 102.4% to $13.51 million but missed EPS estimates, posting a loss of $1.10 per share.
• Analyst sentiment remains broadly positive, with five Buy, one Hold, and one Sell rating; the consensus is Moderate Buy with a $20.75 price target, despite ratings ranging from $19 to Sell.

Mobia Medical, Inc. (NASDAQ:MOBI - Get Free Report) Director Casey Tansey acquired 15,821 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was purchased at an average price of $11.66 per share, with a total value of $184,472.86. Following the transaction, the director owned 284,725 shares in the company, valued at $3,319,893.50. This represents a 5.88% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Mobia Medical Stock Performance

MOBI stock traded down $0.02 during midday trading on Monday, hitting $11.74. 98,126 shares of the company's stock were exchanged, compared to its average volume of 92,796. The stock's fifty day moving average is $12.42. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28. The company has a market cap of $390.82 million and a P/E ratio of -0.61. Mobia Medical, Inc. has a one year low of $10.19 and a one year high of $15.29.

Mobia Medical (NASDAQ:MOBI - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.83) by ($0.27). The business had revenue of $13.51 million during the quarter. The firm's revenue for the quarter was up 102.4% compared to the same quarter last year. On average, analysts expect that Mobia Medical, Inc. will post -2.76 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on MOBI. BTIG Research reaffirmed a "buy" rating and set a $19.00 price target on shares of Mobia Medical in a research report on Wednesday, August 12th. Weiss Ratings initiated coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They issued a "sell (e-)" rating for the company. Bank of America assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set a "buy" rating and a $16.00 price objective on the stock. Wall Street Zen upgraded shares of Mobia Medical from a "sell" rating to a "hold" rating in a research note on Sunday, June 14th. Finally, Zacks Research upgraded Mobia Medical to a "hold" rating in a report on Wednesday, June 3rd. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Mobia Medical presently has an average rating of "Moderate Buy" and a consensus price target of $20.75.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source